Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Syed Mustafa Karim"'
Publikováno v:
Journal of Bone Oncology, Vol 3, Iss 1, Pp 25-35 (2014)
Bone is the most common site for metastasis in patients with solid tumours. Bisphosphonates are an effective treatment for preventing skeletal related events and preserving quality of life in these patients. Zoledronic acid (ZA) is the most potent os
Externí odkaz:
https://doaj.org/article/991a7f591f9c4e41945672d022dede23
Autor:
Syed Mustafa Karim, Jamal Zekri
Publikováno v:
Oncology Reviews, Vol 6, Iss 1 (2012)
Combination chemotherapy is the current strategy of choice for treatment of small cell lung cancer (SCLC). Platinum containing combination regimens are superior to non-platinum regimens in limited stage- SCLC and possibly also in extensive stage-SCLC
Externí odkaz:
https://doaj.org/article/c2e42ba6f83d402c8ce680cac3b55a23
Autor:
Syed Mustafa Karim, Jamal Zekri
Publikováno v:
Journal of global oncology
Purpose Empowering patients with cancer requires that they be continuously informed about their condition. In some Eastern cultures, this concept is often opposed by caregivers. We aim to compare the extent of disclosure desired by actual and presume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ca508cd3f90f4d45f301efe01a124f1
https://doi.org/10.1200/jgo.2015.001925
https://doi.org/10.1200/jgo.2015.001925
Autor:
Zekri J, M Al-Foheidi, M Mokhtar, M Mansour, M Mahrous, Syed Mustafa Karim, Al-Rehaily S, Darwish T, A Rizvi
Publikováno v:
Experimental Oncology. 37:146-150
Background: Lapatinib alone or in combination with other agents, mostly capecitabine is used for patients with advanced/metastatic HER2 positive breast cancer (HER2+BC) after progression on trastuzumab based therapy. Here we report our experience wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9573829b4aed07f4aaa0ff4c2d306d27
https://doi.org/10.31768/2312-8852.2015.37(2):146-150
https://doi.org/10.31768/2312-8852.2015.37(2):146-150
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 16:3957-3960
BACKGROUND: Several studies have examined the relationship between oral contraceptive pill (OCP) use abortions and breast cancer with mixed results. Hormonal changes associated with OCP use and abortion may increase risk of breast cancer over time bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fae4b8c45e55b284ea6789ee5e907f5
https://doi.org/10.7314/apjcp.2015.16.9.3957
https://doi.org/10.7314/apjcp.2015.16.9.3957
Publikováno v:
Journal of Bone Oncology, Vol 3, Iss 1, Pp 25-35 (2014)
Journal of Bone Oncology
Journal of Bone Oncology
Bone is the most common site for metastasis in patients with solid tumours. Bisphosphonates are an effective treatment for preventing skeletal related events and preserving quality of life in these patients. Zoledronic acid (ZA) is the most potent os
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613c8f397996cdee42b08990bfbeaf19
http://www.sciencedirect.com/science/article/pii/S2212137413000705
http://www.sciencedirect.com/science/article/pii/S2212137413000705
Autor:
Tarek Darwish, Jamal E. Zekri, Mervat Mahrous, Hani Abdalla El Taani, Syed Mustafa Karim, Ahmed S. Al-Shehri
Publikováno v:
Journal of Analytical Oncology. 5
Background: Colorectal cancer (CRC) is a significant healthcare burden worldwide and in the Middle East (ME). KRAS mutation confers resistance to epidermal growth factor receptor (EGFR) inhibitors in the treatment of advanced CRC. Data regarding the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3a01d970140515f1f0d2df06ab5fd84
https://doi.org/10.6000/1927-7229.2016.05.02.4
https://doi.org/10.6000/1927-7229.2016.05.02.4
Autor:
Imran Ahmad, Reyad Dada, Ehab Mosaad Abdelghany, Husna Munsoor, Syed Mustafa Karim, Jamal Zekri
Publikováno v:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Background: A substantial number of cancer patients receive chemotherapy until the end of life (EoL). Various factors have been shown to be associated with receipt of chemotherapy until near death. In this study, we determine our average time from la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bad9a5cf8abbc27e15f53d63f927848a
https://pubmed.ncbi.nlm.nih.gov/25810576
https://pubmed.ncbi.nlm.nih.gov/25810576
Autor:
Baker bin Sadiq, Elshami Elamin, Sawsan Bassi, Syed Mustafa Karim, Jamal Zekri, Hossam Abdelrahman, Ehab Mosaad Abdelghany
Publikováno v:
Journal of Palliative Care & Medicine.
Background: It is believed in some Middle Eastern (ME) cultures that disclosure of bad news to cancer patients may cause loss of hope. This is often used to justify withholding such news. In this study, we examine cancer patients ‘preference regard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3efe781b1cdcffdf5eec43c8ba37852c
https://doi.org/10.4172/2165-7386.1000207
https://doi.org/10.4172/2165-7386.1000207
Autor:
Jamal Zekri, Syed Mustafa Karim
Publikováno v:
Palliativesupportive care. 12(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eea09c9c6e441a3bd675833d2e3ef2e8
https://pubmed.ncbi.nlm.nih.gov/22914549
https://pubmed.ncbi.nlm.nih.gov/22914549